Download FREE Report Sample
Download Free sampleLevonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantable form of levonorgestrel is also available in some countries.
Levonorgestrel Market contains market size and forecasts of Levonorgestrel in global, including the following market information:
Global Levonorgestrel Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Levonorgestrel Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Levonorgestrel companies in 2021 (%)
The global Levonorgestrel market was valued at 49 million in 2021 and is projected to reach US$ 61 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Levonorgestrel Table Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Levonorgestrel include Bayer, Paladin Labs, Foundation Consumer Healthcare, Theramex (Teva), Pfizer, Apotex and HRA Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Levonorgestrel manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Levonorgestrel Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Levonorgestrel Market Segment Percentages, by Type, 2021 (%)
Levonorgestrel Table
Mixture Products
Hormone-releasing IUD
Global Levonorgestrel Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Levonorgestrel Market Segment Percentages, by Application, 2021 (%)
Hospital
Drug Store
Online Sale
Global Levonorgestrel Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Levonorgestrel Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Levonorgestrel revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Levonorgestrel revenues share in global market, 2021 (%)
Key companies Levonorgestrel sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Levonorgestrel sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Paladin Labs
Foundation Consumer Healthcare
Theramex (Teva)
Pfizer
Apotex
HRA Pharma
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
